Not a substitute for medical care.
If you have severe BPH symptoms, ProstaRemedy is not equivalent to prescription alpha-blockers or 5-ARI medications. Speak to your urologist about appropriate medical management.
ProstaRemedy works on three mechanisms, each with reasonable evidence behind it. Here's how, plainly.
Lifetime DHT exposure is the primary driver of benign prostatic hyperplasia. The men who happen to be genetically deficient in 5-alpha-reductase (the enzyme that converts testosterone to DHT) almost never develop BPH or male-pattern baldness. So the obvious target is to modestly modulate DHT specifically in prostate tissue, without disrupting systemic testosterone.
This is what Saw Palmetto's lipidosterolic extract does. The fatty acids and plant sterols weakly inhibit 5-alpha-reductase activity in prostate tissue specifically — far less potently than prescription drugs like finasteride, but with a dramatically milder side-effect profile.
Wilt et al., 1998 — Cochrane review of 18 randomised trials of Saw Palmetto in BPH. Modest but consistent improvements in IPSS scores and urinary flow rates over 6-12 month courses at 320mg/day standardised extract.
Beta-Sitosterol and Pygeum bring complementary mechanisms beyond DHT modulation. Beta-Sitosterol affects urinary flow rate and bladder emptying via different cellular pathways. Pygeum reduces tissue inflammation and has independent evidence for reducing nocturia frequency.
Stinging Nettle root provides additional adjunctive support, particularly via lignan binding to SHBG. The combination is synergistic — each ingredient addresses a slightly different aspect of the same overall pattern.
Wilt et al., 2002 — Pygeum review showing modest improvements in nocturia, peak urine flow, and residual urinary volume across 18 controlled trials.
The prostate has the highest zinc concentration of any tissue in the male body. Zinc is structurally required for the testosterone synthesis machinery in the testes and for healthy prostate tissue function. Vitamin D receptors sit directly on prostate tissue, and adequate D3 status is associated with better prostate biomarkers in observational data.
Roughly a third of EU men over 50 are zinc-deficient. Wintertime Vitamin D3 deficiency in northern European men runs above 60%. Closing these gaps is one of the highest-leverage components of any midlife men's health intervention — and it's done at a cost of a few cents per dose.
If you have severe BPH symptoms, ProstaRemedy is not equivalent to prescription alpha-blockers or 5-ARI medications. Speak to your urologist about appropriate medical management.
Saw Palmetto and Pygeum take 4-12 weeks to express their full effects. If you're taking it for two weeks, that's not the protocol.
If you're under 30, on prescription endocrine medication, on anti-coagulants, or have a history of hormone-sensitive conditions — speak to your doctor before starting.
Continue with your doctor-recommended PSA monitoring and DRE schedule. ProstaRemedy supports prostate function; it doesn't detect or treat prostate cancer.